Table 2.
*. Comparison of Patients with Severe hypoalbuminemia <2.8g/dL or Hepatorenal Syndrome or Hepatic Hydrothorax by liver transplant waitlist status Total N=360
| Variable | Listed for transplant n=15 |
Not Listed n=345 |
P Value | |
|---|---|---|---|---|
| Age-years | 54±12 | 58±12 | 0.1799a | |
| Male-no. (%) | 8 (53) | 196 (57) | 0.7901b | |
| Insurance-no. (%) | ||||
| Medicare/Medicaid | 8 (53) | 174 (50) | 0.1294c | |
| Private Insurance | 6 (40) | 79 (23) | ||
| Other | 1 (7) | 92 (27) | ||
| Etiology of Cirrhosis†-no. (%) | ||||
| Alcohol | 4 (27) | 120 (35) | 0.5173b | |
| Hepatitis C | 8 (53) | 121 (35) | 0.1488b | |
| NASH | 4 (27) | 53 (15) | 0.2713c | |
| Hepatitis B | 0 (0) | 14 (4) | 0.9999c | |
| Cholestatic Disease | 6 (40) | 28 (8) | 0.0012c | |
| Median Elixhauser Score-(IQR) | 4 (1–6) | 4 (2–6) | 0.6223d | |
| MELDNa Median(IQR) | 13(11–14) | 11 (9–13) | 0.0452d | |
No statistically significant difference is seen between those listed for liver transplant and those not listed except for MELDNa Score and Cholestatic Disease
P-Values determined by 2 sample t test,
P-Values determined by Chi-squared test t,
P-Value determined by Fishers Exact test
P-Values determined by Wilcoxon Rank Sum test
Table Legend: The table shows a comparison, by liver transplant waitlist status, of patients with MELDNa ≤15 and severe hypoalbuminemia or hepatorenal syndrome or hepatic hydrothorax. These complications have a predicted 1 year risk of death ≥ 14%.
Abbreviations: NASH non-alcoholic steatohepatitis